These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33098328)

  • 21. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia.
    Wang X; Fan Y; Shi R; Li J; Zhao S
    Platelets; 2015; 26(1):72-9. PubMed ID: 24499059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010-2019: A favorable sign of the resiliency of the platelet supply.
    Lasky B; Singh U; Young PP
    Transfusion; 2023 Jul; 63(7):1333-1343. PubMed ID: 37191295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Missing Pieces to the Cold-Stored Platelet Puzzle.
    Zhao H; Devine DV
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A system for the supply of platelets suspended in a storage medium including buffy-coat-derived platelet concentrates in combination with "split" apheresis platelets.
    Gulliksson H; Larsson S; Shanwell A; Pedajas I; Joie M; Flament J
    Transfus Sci; 1997 Mar; 18(1):33-40. PubMed ID: 10174289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hemostatic efficacy of platelet components prepared with pathogen inactivation.
    Corash L
    Transfusion; 2011 Jun; 51(6):1355-6; author reply 1356-7. PubMed ID: 21658040
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
    Gao DY; Neff K; Xiao HY; Matsubayashi H; Cui XD; Bonderman P; Bonderman D; Harvey K; McIntyre JA; Critser J; Miraglia CC; Reid T
    Cryobiology; 1999 May; 38(3):225-35. PubMed ID: 10328912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the effect of a platelet additive solution on apheresis platelet and fibrin network ultrastructure.
    Pretorius E; Crookes R; Oberholzer HM; van der Spuy WJ
    Transfus Apher Sci; 2010 Dec; 43(3):347-351. PubMed ID: 21036668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost implications of implementation of pathogen-inactivated platelets.
    McCullough J; Goldfinger D; Gorlin J; Riley WJ; Sandhu H; Stowell C; Ward D; Clay M; Pulkrabek S; Chrebtow V; Stassinopoulos A
    Transfusion; 2015 Oct; 55(10):2312-20. PubMed ID: 25989465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seven-day storage of apheresis platelets: report of an in vitro study.
    Dumont LJ; VandenBroeke T
    Transfusion; 2003 Feb; 43(2):143-50. PubMed ID: 12559008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress in transfusion for storage of platelets].
    Cazenave JP; Isola H; Gachet C; Aleil B
    Transfus Clin Biol; 2005 Jun; 12(2):226-9. PubMed ID: 15950893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High concentration plasma-reduced plateletapheresis concentrates.
    Perseghin P
    Transfus Apher Sci; 2011 Jun; 44(3):273-6. PubMed ID: 21507725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
    Goodnough LT; Ali S; Despotis G; Dynis M; DiPersio JF
    Vox Sang; 1999; 76(1):43-9. PubMed ID: 9933853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, storage and quality control of platelet concentrates.
    Tynngård N
    Transfus Apher Sci; 2009 Oct; 41(2):97-104. PubMed ID: 19699153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo viability of extended 4°C-stored autologous apheresis platelets.
    Stolla M; Fitzpatrick L; Gettinger I; Bailey SL; Pellham E; Christoffel T; Slichter SJ
    Transfusion; 2018 Oct; 58(10):2407-2413. PubMed ID: 30203458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet concentrates, from whole blood or collected by apheresis?
    van der Meer PF
    Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 24-hour shelf-life of cytapheresis platelet concentrates stored in polyvinyl chloride containers should be extended only with caution.
    Strauss RG; Snyder EL; Eckermann I; Stewart L
    Transfusion; 1987; 27(3):284-7. PubMed ID: 3590294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concepts about current conditions for the preparation and storage of platelets.
    Moroff G; Holme S
    Transfus Med Rev; 1991 Jan; 5(1):48-59. PubMed ID: 1802276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologies.
    Millar D; Hayes C; Jones J; Klapper E; Kniep JN; Luu HS; Noland DK; Petitti L; Poisson JL; Spaepen E; Ye Z; Maurer-Spurej E
    Transfusion; 2020 Sep; 60(9):2067-2078. PubMed ID: 32729161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.